Rapport Therapeutics, Inc. (RAPP) earnings
RAPP earnings moved a median of +2.44% by the close. Quarterly and annual RAPP reports and results, each read against the price at its own news timestamp. Back to the RAPP overview →
15 measured RAPP earnings events.
Where these RAPP earnings landedvs 15 measured RAPP earnings reactions
| Middle 50% of RAPP earnings reactions | -0.57% to +5.48% |
|---|---|
| Median reaction (to close) | +2.44% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 RAPP earnings events with a measured close landed between -0.57% and +5.48%; 67% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Rapport Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.17% | -0.73% | |
| Rapport Therapeutics Reports Third Quarter 2026 Financials and Provides Business Update | Press release | -0.17% | -0.73% | |
| Form 10-Q Rapport Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.51% | +2.44% | |
| Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update | Press release | +2.51% | +2.44% | |
| Form 10-Q Rapport Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.84% | +6.42% | |
| Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update | Press release | -1.84% | +6.42% | |
| Form 10-K Rapport Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.69% | +1.47% | |
| Form 10-Q Rapport Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.38% | -4.30% | |
| Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update | Press release | -0.38% | -4.30% | |
| Form 10-Q Rapport Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +5.48% | |
| Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update | Press release | +0.00% | +5.48% | |
| Form 10-Q Rapport Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +4.21% | |
| Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update | Press release | +0.00% | +4.21% | |
| Form 10-K Rapport Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.45% | +8.34% | |
| Form 10-Q Rapport Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.22% | -0.41% |
Keep exploring
More RAPP: analyst actions → · SEC filings → · RAPP overview →